First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form.

Clin Microbiol Infect

Univ Rouen Normandie, Université de Caen Normandie, INSERM, Normandie Univ, DYNAMICURE UMR 1311, CHU Rouen, Department of Virology, National Reference Center of HIV, F-76000 Rouen, France.

Published: May 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmi.2024.02.013DOI Listing

Publication Analysis

Top Keywords

evidence mother-to-child
4
mother-to-child transmission
4
transmission hiv-1/mo
4
hiv-1/mo intergroup
4
intergroup recombinant
4
recombinant form
4
evidence
1
transmission
1
hiv-1/mo
1
intergroup
1

Similar Publications

[Treatment of adult T-cell leukemia/lymphoma: past, present, and future].

Rinsho Ketsueki

September 2025

Department of Hematology and Rheumatology, Kagoshima University.

Adult T-cell leukemia/lymphoma (ATL) is a T-cell malignancy caused by human T-cell leukemia virus type I (HTLV-1). Treatment strategies have been established by classification of ATL as aggressive (acute, lymphoma, and chronic ATL with any unfavorable prognostic factors) or indolent (smoldering and chronic ATL without any unfavorable prognostic factors). The standard of care (SOC) for aggressive ATL has been dose-intensified multi-agent chemotherapy.

View Article and Find Full Text PDF

HIV mother-to-child transmission (MTCT) continues to pose a significant public health challenge, especially in regions with limited resources, although the worldwide distribution of antiretroviral therapy (ART) has drastically lowered the risk of vertical transmission to even below 1% in some regions. There are still uncertainties regarding the safety of some ART regimens during pregnancy and their longer-term effects on infants who are perinatally exposed to HIV but remain uninfected. This review explores current evidence regarding the interplay between maternal HIV infection, ART during pregnancy, and both maternal and pediatric outcomes.

View Article and Find Full Text PDF

Background/objectives: Emerging evidence suggests that extracellular vesicles (EVs) in breast milk may serve as an abundant source of candidates for regulating metabolism. Our study aims to identify phospholipids derived from human milk EVs (mEVs) that can benefit people with obesity.

Methods: Infant mice were either fed with formula milk or breastfed to investigate whether mEVs affect adipose tissue physiology in infants.

View Article and Find Full Text PDF

Pregnancy introduces significant physiological changes that alter the pharmacokinetics (PK) of antiretroviral therapy (ART), impacting its safety and efficacy in HIV-positive women. Optimizing ART during pregnancy is critical to maintaining maternal virological suppression and preventing mother-to-child transmission (MTCT) of HIV. This review evaluates the impact of pregnancy-induced PK changes on ART and proposes strategies for tailored regimens to improve outcomes.

View Article and Find Full Text PDF

Despite well-documented behavioral changes, the development of neuropsychological substrates underlying inhibitory control remains unknown, hindering understanding of this construct over time. Stability and change in N2, a neural correlate of inhibitory control, and its crosslagged, bidirectional associations with maternal emotion characteristics were examined in 121 preschoolers (59% female, predominantly White) between 2014 and 2017. N2 was stable from 3 to 5 years of age.

View Article and Find Full Text PDF